Assignee
EVOTEC INT GMBH
DE·8 granted patents·10 pending applications·2 citations·filing 2014–2025
Top patents by PatentIndex Score
18 records- 0176US2023160877A1Assay for drug discovery based on in vitro differentiated cellsEVOTEC INT GMBH·Filed 2023·Application pending·0 cites
- 0273US12258338B2Modulators of the integrated stress response pathwayEVOTEC INT GMBH·Filed 2020·Granted Mar 25, 2025·1 cites·31 claims
- 0367US12275796B2Interferon-associated antigen binding proteins and uses thereofEVOTEC INT GMBH·Filed 2023·Granted Apr 15, 2025·0 cites·31 claims
- 0467US9708274B2Sulfoximine substituted quinazolines for pharmaceutical compositionsEVOTEC INT GMBH·Filed 2015·Granted Jul 18, 2017·1 cites·10 claims
- 0564US11835433B2Non-invasive, in vitro functional tissue assay systemsEVOTEC INT GMBH·Filed 2020·Granted Dec 5, 2023·0 cites·15 claims
- 0664US2025283046A1New Cell Populations and Means and Methods for their Differentiation and PreservationEVOTEC INT GMBH·Filed 2023·Application pending·0 cites
- 0755US2023242655A1Interferon-associated antigen binding proteins and uses thereofEVOTEC INT GMBH·Filed 2020·Application pending·0 cites
- 0854US2025188071A1Modulators of the integrated stress response pathwayEVOTEC INT GMBH·Filed 2025·Application pending·0 cites
- 0952US2025320302A1Interferon-associated antigen binding proteins for use for the treatment or prevention of coronavirus infectionEVOTEC INT GMBH·Filed 2022·Application pending·0 cites
- 1051US2023391725A1Modulators of the integrated stress response pathwayEVOTEC INT GMBH·Filed 2021·Application pending·0 cites
- 1150US2023391763A1Modulators of the integrated stress response pathwayEVOTEC INT GMBH·Filed 2021·Application pending·0 cites
- 1249US10370378B2Treatment of sleep disordersEVOTEC INT GMBH·Filed 2014·Granted Aug 6, 2019·0 cites·18 claims
- 1348US12441720B2Modulators of the integrated stress response pathwayEVOTEC INT GMBH·Filed 2021·Granted Oct 14, 2025·0 cites·25 claims
- 1448US2023028476A1Interferon-associated antigen binding proteins for use in treating hepatitis b infectionEVOTEC INT GMBH·Filed 2020·Application pending·0 cites
- 1547US2023125481A1Modulators of the integrated stress response pathwayEVOTEC INT GMBH·Filed 2021·Application pending·0 cites
- 1645US10093660B2Sulfoximine substituted quinazolines for pharmaceutical compositionsEVOTEC INT GMBH·Filed 2014·Granted Oct 9, 2018·0 cites·19 claims
- 1742US2022213078A1Modulators of the integrated stress response pathwayEVOTEC INT GMBH·Filed 2020·Application pending·0 cites
- 1832US10167296B2Sulfoximine substituted quinazolines for pharmaceutical compositionsEVOTEC INT GMBH·Filed 2015·Granted Jan 1, 2019·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when EVOTEC INT GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →